Vincerx Pharma Dirección
Dirección controles de criterios 4/4
Vincerx Pharma's CEO is Ahmed Hamdy, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is $734.95K, comprised of 65.2% salary and 34.8% bonuses, including company stock and options. directly owns 5.55% of the company’s shares, worth $625.70K. The average tenure of the management team and the board of directors is 3.5 years and 3.8 years respectively.
Información clave
Ahmed Hamdy
Chief Executive Officer (CEO)
US$735.0k
Compensación total
| Porcentaje del salario del CEO | 65.2% |
| Permanencia del CEO | 3.9yrs |
| Participación del CEO | 5.6% |
| Permanencia media de la dirección | 3.5yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely
Aug 21
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Jul 18Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Mar 30Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Sep 22Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?
Jun 24Vincerx Pharma doses first patient in early-stage VIP152 cancer study
Jun 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$38m |
| Dec 31 2023 | US$735k | US$479k | -US$40m |
| Sep 30 2023 | n/a | n/a | -US$47m |
| Jun 30 2023 | n/a | n/a | -US$54m |
| Mar 31 2023 | n/a | n/a | -US$61m |
| Dec 31 2022 | US$1m | US$460k | -US$63m |
| Sep 30 2022 | n/a | n/a | -US$58m |
| Jun 30 2022 | n/a | n/a | -US$66m |
| Mar 31 2022 | n/a | n/a | -US$49m |
| Dec 31 2021 | US$615k | US$460k | -US$39m |
| Sep 30 2021 | n/a | n/a | -US$49m |
| Jun 30 2021 | n/a | n/a | -US$25m |
| Mar 31 2021 | n/a | n/a | -US$23m |
| Dec 31 2020 | US$622k | US$15k | -US$17m |
Compensación vs. Mercado: Ahmed's total compensation ($USD734.95K) is about average for companies of similar size in the US market ($USD655.65K).
Compensación vs. Ingresos: Ahmed's compensation has been consistent with company performance over the past year.
CEO
Ahmed Hamdy (59 yo)
3.9yrs
Permanencia
US$734,953
Compensación
Dr. Ahmed M. Hamdy, M.D., is Co-Founder of Vincerx Pharma, Inc. (formerly known as Vincera Pharma, Inc.) and has been its Chief Executive Officer and Chairman of the Board since December 2020. He served as...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 3.9yrs | US$734.95k | 5.55% $ 625.7k | |
| Co-Founder | 3.9yrs | US$668.96k | 0.28% $ 31.5k | |
| Chief Financial Officer | 3.9yrs | US$565.67k | 0.11% $ 12.1k | |
| Founder | 3.7yrs | US$3.16m | sin datos | |
| Founder & Chairman of Scientific Advisory Board | no data | sin datos | 5.24% $ 590.6k | |
| Chief Scientific Officer | 3.7yrs | sin datos | sin datos | |
| Vice President of Investor Relations & Corporate Communications and Chief of Staff | 1.3yrs | sin datos | sin datos | |
| Vice President of Quality Operations & Compliance | 1.8yrs | sin datos | sin datos | |
| Senior Director of People & Culture and Head of Human Resource | 3.3yrs | sin datos | sin datos | |
| Executive Chief Development Officer | 3.5yrs | sin datos | sin datos | |
| Chief Business Officer | 1.4yrs | sin datos | sin datos | |
| VP of Biologics Development and Manufacturing and Sr. VP of Chemistry & Manufacturing | 1.4yrs | sin datos | sin datos |
3.5yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: VINC's management team is considered experienced (3.5 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 3.9yrs | US$734.95k | 5.55% $ 625.7k | |
| Co-Founder | 3.9yrs | US$668.96k | 0.28% $ 31.5k | |
| Founder & Chairman of Scientific Advisory Board | 3.6yrs | sin datos | 5.24% $ 590.6k | |
| Independent Director | 3.9yrs | US$69.14k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$47.89k | 0.18% $ 20.0k | |
| Member of Scientific Advisory Board | 3.6yrs | sin datos | sin datos | |
| Independent Director | 3.9yrs | US$52.89k | 0.062% $ 7.0k | |
| Independent Director | 3.5yrs | US$47.89k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.6yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.6yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.6yrs | sin datos | sin datos | |
| Independent Director | 3.9yrs | US$47.89k | 0.0026% $ 291.9 |
3.8yrs
Permanencia media
56yo
Promedio de edad
Junta con experiencia: VINC's board of directors are considered experienced (3.8 years average tenure).